Company intelligence / Profile preview

Northern Therapeutics

Montreal, Quebec, Canadanortherntherapeutics.com ↗
Ownership
Private
Employees
~6
Development stage
Other
01

Overview

Northern Therapeutics has developed and tested cell and gene therapies targeting pulmonary diseases, notably pulmonary arterial hypertension. Their nitric oxide synthase-based therapies have reached early clinical development, with at least one program discontinued and others pending further advancement. The company has also filed patents for cell-based therapies for the pulmonary system. A first-in-human trial of a related product in critically ill patients showed favorable tolerability and safety.

Therapeutic areas
Infectious DiseasesCardiovascular
Modalities
Gene therapyCell therapyAutologous cell-based gene therapyNitric oxide synthase gene therapy
Industry
Biotech
02

Drug pipeline

6 assets

eNOS-transfected autologous endothelial progenitor cells

2

5 more assets in the full pipeline.

Request access →
03

Partnerships

MaxCyte Inc. [for electroporation/gene delivery technology]University of Toronto [academic collaboration on autologous cell-based therapies]

Beyond the preview

Go deeper on Northern Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Northern Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call